Literature DB >> 12409349

Molecular epidemiology of pneumococcal carriage among children with upper respiratory tract infections in Hanoi, Vietnam.

D Bogaert1, N T Ha, M Sluijter, N Lemmens, R De Groot, P W M Hermans.   

Abstract

To investigate the molecular epidemiology of pneumococcal nasopharyngeal carriage in Hanoi, Vietnam, we studied 84 pneumococcal strains retrieved from children with upper respiratory tract infections. Serotypes 23F (32%), 19F (21%), 6B (13%), and 14 (10%) were found most often. A significant number of strains were antibiotic resistant. Fifty-two percent of the strains were (intermediate) resistant to penicillin, 87% were (intermediate) resistant to co-trimoxazole, 76% were resistant to tetracycline, 73% were resistant to erythromycin, and 39% were (intermediate) resistant to cefotaxime. Seventy-five percent were resistant to three or more classes of antibiotics. A high degree of genetic heterogeneity among the penicillin resistance genes was observed. In addition, the tetracycline resistance gene tet(M) and the erythromycin resistance gene erm(B) were predominantly observed among the isolates. Molecular analysis of the 84 isolates by restriction fragment end labeling (RFEL) revealed 35 distinct genotypes. Twelve of these genotypes represented a total of eight genetic clusters with 61 isolates (73%). The two largest clusters contained 24 and 12 isolates, and the isolates in those clusters were identical to the two internationally spreading multidrug-resistant clones Spain 23F-1 and Taiwan 19F-14, respectively. The remaining RFEL types were Vietnam specific, as they did not match the types in our reference collection of 193 distinct RFEL types from 16 countries. Furthermore, 57 of the 61 horizontally spreading isolates (93%) in the eight genetic clusters were covered by the seven-valent conjugate vaccine, whereas this vaccine covered only 43% of the isolates with unique genotypes. According to the serotype distribution of the nasopharyngeal pneumococcal isolates, this study suggests a high potential benefit of the seven-valent pneumococcal conjugate vaccine for children in Hanoi.

Entities:  

Mesh:

Year:  2002        PMID: 12409349      PMCID: PMC139650          DOI: 10.1128/JCM.40.11.3903-3908.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  37 in total

Review 1.  Evaluation of vaccines for the prevention of pneumonia in children in developing countries.

Authors:  K Mulholland; O Levine; H Nohynek; B M Greenwood
Journal:  Epidemiol Rev       Date:  1999       Impact factor: 6.222

2.  Molecular epidemiology of penicillin-nonsusceptible Streptococcus pneumoniae among children in Greece.

Authors:  D Bogaert; G A Syrogiannopoulos; I N Grivea; R de Groot; N G Beratis; P W Hermans
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska, 1991-1998.

Authors:  K M Rudolph; A J Parkinson; A L Reasonover; L R Bulkow; D J Parks; J C Butler
Journal:  J Infect Dis       Date:  2000-07-12       Impact factor: 5.226

4.  Evaluation of the Vitek 2 system for susceptibility testing of Streptococcus pneumoniae isolates.

Authors:  W H Goessens; N Lemmens-den Toom; J Hageman; P W Hermans; M Sluijter; R de Groot; H A Verbrugh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-08       Impact factor: 3.267

5.  Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.

Authors:  S Black; H Shinefield; B Fireman; E Lewis; P Ray; J R Hansen; L Elvin; K M Ensor; J Hackell; G Siber; F Malinoski; D Madore; I Chang; R Kohberger; W Watson; R Austrian; K Edwards
Journal:  Pediatr Infect Dis J       Date:  2000-03       Impact factor: 2.129

6.  Preparation for a pneumococcal vaccine trial in The Gambia: individual or community randomisation?

Authors:  S Jaffar; A Leach; A J Hall; S Obaro; K P McAdam; P G Smith; B M Greenwood
Journal:  Vaccine       Date:  1999-11-12       Impact factor: 3.641

7.  Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines.

Authors:  R von Kries; A Siedler; H J Schmitt; R R Reinert
Journal:  Clin Infect Dis       Date:  2000-08-30       Impact factor: 9.079

8.  Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.

Authors:  E Saeland; H Jakobsen; G Ingolfsdottir; S T Sigurdardottir; I Jonsdottir
Journal:  J Infect Dis       Date:  2000-12-08       Impact factor: 5.226

9.  Efficacy of a pneumococcal conjugate vaccine against acute otitis media.

Authors:  J Eskola; T Kilpi; A Palmu; J Jokinen; J Haapakoski; E Herva; A Takala; H Käyhty; P Karma; R Kohberger; G Siber; P H Mäkelä
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

10.  Genetic diversity of the tet(M) gene in tetracycline-resistant clonal lineages of Streptococcus pneumoniae.

Authors:  N Doherty; K Trzcinski; P Pickerill; P Zawadzki; C G Dowson
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

View more
  9 in total

1.  Molecular epidemiology of penicillin-susceptible non-beta-lactam-resistant Streptococcus pneumoniae isolates from Greek children.

Authors:  D Bogaert; P W M Hermans; I N Grivea; G S Katopodis; T J Mitchell; M Sluijter; R De Groot; N G Beratis; G A Syrogiannopoulos
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Decreased Streptococcus pneumoniae susceptibility to oral antibiotics among children in rural Vietnam: a community study.

Authors:  Nguyen Quynh Hoa; Nguyen V Trung; Mattias Larsson; Bo Eriksson; Ho D Phuc; Nguyen Tk Chuc; Cecilia Stalsby Lundborg
Journal:  BMC Infect Dis       Date:  2010-03-31       Impact factor: 3.090

3.  Enhanced determination of Streptococcus pneumoniae serotypes associated with invasive disease in Laos by using a real-time polymerase chain reaction serotyping assay with cerebrospinal fluid.

Authors:  Catrin E Moore; Amphone Sengduangphachanh; Thaksinaporn Thaojaikong; Joy Sirisouk; Dona Foster; Rattanaphone Phetsouvanh; Lesley McGee; Derrick W Crook; Paul N Newton; Sharon J Peacock
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

4.  Immunization with a combination of three pneumococcal proteins confers additive and broad protection against Streptococcus pneumoniae Infections in Mice.

Authors:  Kaifeng Wu; Xuemei Zhang; Jing Shi; Nan Li; Dairong Li; Miao Luo; Ju Cao; Nanlin Yin; Hong Wang; Wenchun Xu; Yujuan He; Yibing Yin
Journal:  Infect Immun       Date:  2009-12-28       Impact factor: 3.441

5.  Safety and reactogenicity of primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Vietnamese infants: a randomised, controlled trial.

Authors:  Tran Ngoc Huu; Nguyen Trong Toan; Ha Manh Tuan; Ho Lu Viet; Pham Le Thanh Binh; Ta-Wen Yu; Fakrudeen Shafi; Ahsan Habib; Dorota Borys
Journal:  BMC Infect Dis       Date:  2013-02-21       Impact factor: 3.090

Review 6.  Penicillin-Resistant trend of Streptococcus pneumoniae in Asia: A systematic review.

Authors:  Setareh Mamishi; Sepideh Moradkhani; Shima Mahmoudi; Reihaneh Hosseinpour-Sadeghi; Babak Pourakbari
Journal:  Iran J Microbiol       Date:  2014-08

7.  Cephalosporin-resistant pneumococci and sickle cell disease.

Authors:  Martha L Miller; Caroline A Obert; Geli Gao; Najat C Daw; Patricia Flynn; Elaine Tuomanen
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

Review 8.  Carriage of Streptococcus pneumoniae and other respiratory bacterial pathogens in low and lower-middle income countries: a systematic review and meta-analysis.

Authors:  Richard A Adegbola; Rodrigo DeAntonio; Philip C Hill; Anna Roca; Effua Usuf; Bernard Hoet; Brian M Greenwood
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

9.  Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape.

Authors:  Nicholas J Croucher; Claire Chewapreecha; William P Hanage; Simon R Harris; Lesley McGee; Mark van der Linden; Jae-Hoon Song; Kwan Soo Ko; Herminia de Lencastre; Claudia Turner; Fan Yang; Raquel Sá-Leão; Bernard Beall; Keith P Klugman; Julian Parkhill; Paul Turner; Stephen D Bentley
Journal:  Genome Biol Evol       Date:  2014-06-10       Impact factor: 3.416

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.